Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OMPI of America is the U.S. subsidiary of Stevanato Group focused on commercial manufacturing and supply of pharmaceutical glass primary packaging, drug containment solutions, and selected drug delivery devices for biopharma customers. The business supports injectable medicines with products such as vials, syringes, cartridges, and related containment systems rather than developing therapeutic drugs of its own. Its U.S. operations include the Fishers, Indiana plant, which was built to expand domestic vial production capacity and serve North American pharmaceutical customers. The company operates as part of Stevanato Group’s broader integrated offering spanning drug containment, drug delivery, and diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMPI of America.